Abstract The clinical course of a Paroxysmal Nocturnal Hemoglobinuria (PNH) patient receiving treatment with terminal complement by ravulizumab and SARS-CoV2…
![](https://analesranm.es/wp-content/uploads/2018/08/user_hombre.jpg)
Pablo Estival
Hospital Clinico Universitario San Carlos, Department of Hematology, The Clínic Institute of Hematological and Oncological Diseases, Madrid, Spain